1. Venturella G, Ferraro V, Cirlincione F, Gargano ML. Medicinal mushrooms: bioactive compounds, use, and clinical trials. Int J Mol Sci. 2021 Jan;22(2):634. DOI: 10.3390/ijms22020634

2. American Herbal Pharmacopoeia. Reishi mushroom - Ganoderma lucidum: standards of analysis, quality control, and therapeutics. Santa Cruz: American Herbal Pharmacopoeia; 2006.

3. Hobbs C. Medicinal mushrooms: an exploration of tradition, healing, & culture. Summertown; Botanica Press; 1995.

4. Zheng C, Rangsinth P, Shiu PHT, Wang W, Li R, Li J, et al. A review on the sources, structures, and pharmacological activities of lucidenic acids. Molecules. 2023 Feb;28(4):1756. DOI: 10.3390/molecules28041756

5. Galappaththi MCA, Patabendige NM, Premarathne BM, Hapuarachchi KK, Tibpromma S, Dai DQ, et al. A review of Ganoderma triterpenoids and their bioactivities. Biomolecules. 2022 Dec;13(1):24. DOI: 10.3390/biom13010024

6. Cör D, Knez Ž, Knez Hrnčič M. Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: a review. Molecules. 2018 Mar;23(3):649. DOI: 10.3390/molecules23030649

7. Wachtel-Galor S, Benzie IFF. Ganoderma lucidum (lingzhi or reishi): a medicinal mushroom. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton: CRC Press/Taylor & Francis; 2011. Chapter 9.

8. National Cancer Institute. Medicinal mushrooms (PDQ®)–health professional version [Internet]. Bethesda: National Institutes of Health; 2024 [cited 2025 Apr 1]. Available from: https://www.cancer.gov/about-cancer/treatment/cam/hp/mushrooms-pdq

9. Thomsen M. Phytotherapy desk reference. 5th ed. 2020.

10. Jin X, Ruiz Beguerie J, Sze DMY, Chan GCF. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016 Apr;4(4):CD007731. DOI: 10.1002/14651858.CD007731.pub3

11. Sohretoglu D, Huang S. Ganoderma lucidum polysaccharides as an anti-cancer agent. Anticancer Agents Med Chem. 2018;18(5):667-674. DOI: 10.2174/1871520617666171113121246

12. Gao Y, Dai X, Chen G, Ye J, Zhou S. A randomized, placebo-controlled, multi-center study of Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly) in patients with advanced lung cancer. Int J Med Mushrooms. 2003;5(4):368-381. DOI: 10.1615/InterJMedicMush.v5.i4.40

13. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of Ganopoly® (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003 Aug;32(3):201-215. DOI: 10.1081/imm-120022979

14. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of a Ganoderma lucidum (Curr.: Fr.) P. Karst. extract (Ganopoly) in patients with advanced cancer. Int J Med Mushrooms. 2002;4(3):207-214. DOI: 10.1615/IntJMedMushr.v4.i3.30

15. Zhong L, Yan P, Lam WC, Yao L, Bian Z. Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10:703. DOI: 10.3389/fphar.2019.00703

16. Oka S, Tanaka S, Yoshida S, Hiyama T, Ueno Y, Ito M, et al. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J Med Sci. 2010 Mar;59(1):1-6.

17. Chiu HF, Fu HY, Lu YY, Han YC, Shen YC, Venkatakrishnan K, et al. Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers. Pharm Biol. 2017 Dec;55(1):1041-1046. DOI: 10.1080/13880209.2017.1288750

18. Ma HT, Hsieh JF, Chen ST. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 2015 Jun;114:109-113. DOI: 10.1016/j.phytochem.2015.02.017

19. Li H, Xiao Y, Han L, Jia Y, Luo S, Zhang D, et al. Ganoderma lucidum polysaccharides ameliorated depression-like behaviors in the chronic social defeat stress depression model via modulation of Dectin-1 and the innate immune system. Brain Res Bull. 2021 Jun;171:16-24. DOI: 10.1016/j.brainresbull.2021.03.002

20. Cui XY, Cui SY, Zhang J, Wang ZJ, Yu B, Sheng ZF, et al. Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol. 2012 Feb;139(3):796-800. DOI: 10.1016/j.jep.2011.12.020

21. Mitra S, Mitra M, Nandi DK, Saha M, Bandyopadhyay A. Efficacy of lingzhi or reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes) supplementation on psychological stress and selective fitness profile parameters in female college students in West Bengal, India. Int J Med Mushrooms. 2024;26(11):51-64. DOI: 10.1615/IntJMedMushrooms.2024055300

22. Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005;8(1):53-58. DOI: 10.1089/jmf.2005.8.53

23. Chu TTW, Benzie IFF, Lam CWK, Fok BSP, Lee KKC, Tomlinson B. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr. 2012 Apr;107(7):1017-1027. DOI: 10.1017/S0007114511003795

24. Gao Y, Chen G, Dai X, Ye J, Zhou S. A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with coronary heart disease. Int J Med Mushrooms. 2004;6(4);327-334. DOI: 10.1615/IntJMedMushr.v6.i4.30

25. Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of lingzhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int J Med Mushrooms. 2004;6(1):33-40. DOI: 10.1615/IntJMedMushr.v6.i1.30

26. Collado Mateo D, Pazzi F, Domínguez Muñoz FJ, Martín Martínez JP, Olivares PR, Gusi N, et al. Ganoderma lucidum improves physical fitness in women with fibromyalgia. Nutr Hosp. 2015 Nov;32(5):2126-2135. DOI: 10.3305/nh.2015.32.5.9601

27. Chen JK, Chen TT, Crampton L. Chinese medical herbology and pharmacology. California: Art of Medicine Press; 2004.

28. Huang K. The pharmacology of Chinese herbs. Boca Raton: CRC Press; 1993.

29. Chen SN, Nan FH, Liu MW, Yang MF, Chang YC, Chen S. Evaluation of immune modulation by β-1,3; 1,6 D-glucan derived from Ganoderma lucidum in healthy adult volunteers, a randomized controlled trial. Foods. 2023 Feb;12(3):659. DOI: 10.3390/foods12030659

30. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998 Nov;49(6):1651-1657. DOI: 10.1016/s0031-9422(98)00254-4

31. Gao Y, Tang W, Gao H, Chan E, Lan J, Zhou S. Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats. J Med Food. 2004;7(4):417-421. DOI: 10.1089/jmf.2004.7.417

32. Gao Y, Zhou S, Wen J, Huang M, Xu A. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci. 2002 Dec;72(6):731-745. DOI: 10.1016/s0024-3205(02)02301-9

33. Gupta A, Kirar V, Keshri GK, Gola S, Yadav A, Negi PS, et al. Wound healing activity of an aqueous extract of the lingzhi or reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes). Int J Med Mushrooms. 2014;16(4):345-354. DOI: 10.1615/intjmedmushrooms.v16.i4.50

34. Cheng PG, Phan CW, Sabaratnam V, Abdullah N, Abdulla MA, Kuppusamy UR. Polysaccharides-rich extract of Ganoderma lucidum (M.A. Curtis:Fr.) P. Karst accelerates wound healing in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2013;2013:671252. DOI: 10.1155/2013/671252

35. Donatini B. Control of oral human papillomavirus (HPV) by medicinal mushrooms, Trametes versicolor and Ganoderma lucidum: a preliminary clinical trial. Int J Med Mushrooms. 2014;16(5):497-498. DOI: 10.1615/intjmedmushrooms.v16.i5.80

36. Chen JK, Chen TT, editors. Chinese medical herbology and pharmacology. City of Industry: Art of Medicine Press, Inc.; 2004. p. 770-771.

37. Lin ZB. Presented at: 16th World Congress of Basic and Clinical Pharmacology; 2010 Jul 17-23; Copenhagen, Denmark.

38. Health Canada. Mushrooms [Internet]. Ottawa: Government of Canada; 2024 Jun [cited 2025 May 14]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=mushrooms.champignons2&lang=eng

39. Elkhateeb WA, Daba GM, Elnahas MO, Thomas PW. Anticoagulant capacities of some medicinal mushrooms. RCH J Pharma Sci. 2019;5(4):1-9. DOI: 10.20431/2455-1538.0504001

40. Neuwirthová J, Urbánková P, Smilek P. Immunostimulatory and anticancer effect of reishi and coriol extracts at the level of clinical studies and their implementation in practice. Klin Onkol. 2020 Winter;33(6):426-434.

41. Milosavljevic A, Barnes J. Ganoderma lucidum. J Prim Health Care. 2023;15(3):290-292. DOI: 10.1071/HC23105

42. Sum SSM, Ziegler J. Lingzhi and cordyceps: two commonly used Chinese medicinal herbs, safe or not? Nutr Clin Pract. 2016 Oct;31(5):695-697. DOI: 10.1177/0884533616662990

43. Gardner Z, McGuffin M. American Herbal Products Association’s botanical safety handbook. 2nd ed. Boca Raton: CRC Press; 2013.

44. Henao SLD, Urrego SA, Cano AM, Hiuita EA. Randomized clinical trial for the evaluation of immune modulation by yoghurt enriched with β-glucans from lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), in children from Medellin, Colombia. Int J Med Mushrooms. 2018;20(8):705-716. DOI: 10.1615/IntJMedMushrooms.2018026986

45. Peire, De Ana F, Luces S, Blanco R, Simon. PP-30: clinical utility and safety of Ganoderma lucidum extract in acute lymphoblastic leukaemia as a adjuvant therapy: a case report. Arch Dis Child. 2017;102(10):A27.1-A27. DOI: 10.1136/archdischild-2017-esdppp.57

46. Chan WK, Lam DTW, Law HKW, Wong WT, Koo MWL, Lai ASY, et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med. 2005 Dec;11(6):1047-1057. DOI: 10.1089/acm.2005.11.1047

47. Sierra-Patev S, Min B, Naranjo-Ortiz M, Looney B, Konkel Z, Slot JC, et al. A global phylogenomic analysis of the shiitake genus Lentinula. Proc Natl Acad Sci USA. 2023 Mar;120(10):e2214076120. DOI: 10.1073/pnas.2214076120

48. Ina K, Kataoka T, Ando T. The use of lentinan for treating gastric cancer. Anticancer Agents Med Chem. 2013 Jun;13(5):681-688. DOI: 10.2174/1871520611313050002

49. Chan GCF, Chan WK, Sze DMY. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009 Jun;2:25. DOI: 10.1186/1756-8722-2-25

50. Trivedi S, Patel K, Belgamwar V, Wadher K. Functional polysaccharide lentinan: role in anti-cancer therapies and management of carcinomas. Pharmacol Res Mod Chin Med. 2022;2:100045. DOI: 10.1016/j.prmcm.2022.100045

51. Zhao C, Yan H, Pang W, Wu T, Kong X, Li X, et al. Lentinan combined with cisplatin for the treatment of non-small cell lung cancer. Medicine (Baltimore). 2021 Mar;100(12):e25220. DOI: 10.1097/MD.0000000000025220

52. Wang XE, Wang YH, Zhou Q, Peng M, Zhang J, Chen M, et al. Immunomodulatory effect of lentinan on aberrant T subsets and cytokines profile in non-small cell lung cancer patients. Pathol Oncol Res. 2020 Jan;26(1):499-505. DOI: 10.1007/s12253-018-0545-y

53. Yin X, Ying J, Li L, Zhang H, Wang H. A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer. Indian J Cancer. 2015 Nov;52 Suppl 1:e29-e31. DOI: 10.4103/0019-509X.168953

54. Ina K, Furuta R, Kataoka T, Kayukawa S, Yoshida T, Miwa T, et al. Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy. World J Clin Oncol. 2011 Oct;2(10):339-343. DOI: 10.5306/wjco.v2.i10.339

55. Yamaguchi Y, Miyahara E, Hihara J. Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot study. Am J Chin Med. 2011;39(3):451-459. DOI: 10.1142/S0192415X11008956

56. Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GBKS. Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem. 2010;17(22):2419-2430. DOI: 10.2174/092986710791698495

57. Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res. 2009 Jul;29(7):2739-2745.

58. Wang W, Dai X, Ouyang X. [Efficacy of Lentinan combined with chemotherapy in advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2006 Feb 20;9(1):78-81. DOI: 10.3779/j.issn.1009-3419.2006.01.20

59. Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med. 1998;29(5-6):305-330.

60. Drori A, Shabat Y, Ben Ya'acov A, Danay O, Levanon D, Zolotarov L, et al. Extracts from Lentinula edodes (shiitake) edible mushrooms enriched with vitamin D exert an anti-inflammatory hepatoprotective effect. J Med Food. 2016 Apr;19(4):383-389. DOI: 10.1089/jmf.2015.0111

61. Matsuhisa K, Yamane S, Okamoto T, Watari A, Kondoh M, Matsuura Y, et al. Anti-HCV effect of Lentinula edodes mycelia solid culture extracts and low-molecular-weight lignin. Biochem Biophys Res Commun. 2015 Jun;462(1):52-57. DOI: 10.1016/j.bbrc.2015.04.104

62. Dai X, Stanilka JM, Rowe CA, Esteves EA, Nieves C, Spaiser SJ, et al. Consuming Lentinula edodes (shiitake) mushrooms daily improves human immunity: a randomized dietary intervention in healthy young adults. J Am Coll Nutr. 2015;34(6):478-487. DOI: 10.1080/07315724.2014.950391

63. Yoo HJ. Preventive effects of shiitake mushroom extract on candida stomatitis. J Dent Rehabil Appl Sci. 2021;37(3):123-129. DOI: 10.14368/jdras.2021.37.3.123

64. Hearst R, Nelson D, McCollum G, Millar BC, Maeda Y, Goldsmith CE, et al. An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms. Complement Ther Clin Pract. 2009 Feb;15(1):5-7. DOI: 10.1016/j.ctcp.2008.10.002

65. Song Y, Chen Y, Cai H, Zhu G, Zeng Y, Abuduxukuer Z, et al. Lentinan attenuates allergic airway inflammation and epithelial barrier dysfunction in asthma via inhibition of the PI3K/AKT/NF-κB pathway. Phytomedicine. 2024 Nov;134:155965. DOI: 10.1016/j.phymed.2024.155965

66. Alagbaoso CA, Mizuno M. Lentinula edodes polysaccharides suppressed pro-inflammatory cytokines expression and colitis in mice. Arq Gastroenterol. 2022;59(2):288-295. DOI: 10.1590/S0004-2803.202202000-51

67. Alagbaoso CA, Mizuno M. Polysaccharides from shiitake culinary-medicinal mushroom Lentinus edodes (Agaricomycetes) suppress pMLKL-mediated necroptotic cell death and colitis in mice. Int J Med Mushrooms. 2021;23(7):13-26. DOI: 10.1615/IntJMedMushrooms.2021038850

68. Hu S, Luo J, Guo P, Du T, Liu X, He M, et al. Lentinan alleviates diabetic cardiomyopathy by suppressing CAV1/SDHA-regulated mitochondrial dysfunction. Biomed Pharmacother. 2023 Nov;167:115645. DOI: 10.1016/j.biopha.2023.115645

69. Du T, Fang Q, Zhang Z, Zhu C, Xu R, Chen G, et al. Lentinan protects against nonalcoholic fatty liver disease by reducing oxidative stress and apoptosis via the PPARα pathway. Metabolites. 2022 Jan;12(1):55. DOI: 10.3390/metabo12010055

70. Yang X, Zheng M, Zhou M, Zhou L, Ge X, Pang N, et al. Lentinan supplementation protects the gut-liver axis and prevents steatohepatitis: the role of gut microbiota involved. Front Nutr. 2021;8:803691. DOI: 10.3389/fnut.2021.803691

71. Anwar H, Suchodolski JS, Ullah MI, Hussain G, Shabbir MZ, Mustafa I, et al. Shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes), supplementation alters gut microbiome and corrects dyslipidemia in rats. Int J Med Mushrooms. 2019;21(1):79-88. DOI: 10.1615/IntJMedMushrooms.2018029348

72. Nisar J, Mustafa I, Anwar H, Sohail MU, Hussain G, Ullah MI, et al. Shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes): a species with antioxidant, immunomodulatory, and hepatoprotective activities in hypercholesterolemic rats. Int J Med Mushrooms. 2017;19(11):981-990. DOI: 10.1615/IntJMedMushrooms.2017024504

73. Yu S, Wu X, Ferguson M, Simmen RC, Cleves MA, Simmen FA, et al. Diets containing shiitake mushroom reduce serum lipids and serum lipophilic antioxidant capacity in rats. J Nutr. 2016 Dec;146(12):2491-2496. DOI: 10.3945/jn.116.239806

74. Kabir Y, Yamaguchi M, Kimura S. Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 1987 Oct;33(5):341-346. DOI: 10.3177/jnsv.33.341

75. NCATS Inxight Drugs. Lentinan [Internet]. Bethesda: National Institutes of Health; [cited 2025 Apr 2]. Available from: https://drugs.ncats.io/substance/6751655D1D

76. Zhang Y, Zhang M, Jiang Y, Li X, He Y, Zeng P, et al. Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China. J Cancer Res Clin Oncol. 2018 Nov;144(11):2177-2186. DOI: 10.1007/s00432-018-2718-1

77. Jones K. Shiitake: the healing mushroom. Rochester: Healing Arts Press; 1995.

78. Sakanovic S, George S, Topham E. Don’t miss shiitake dermatitis: a case report. Br J Gen Pract. 2014 Aug;64(625):426-427. DOI: 10.3399/bjgp14X681193

79. Hérault M, Waton J, Bursztejn AC, Schmutz JL, Barbaud A. [Shiitake dermatitis now occurs in France]. Ann Dermatol Venereol. 2010 Apr;137(4):290-293. DOI: 10.1016/j.annder.2010.02.007

80. Camargo IF, Caetano ELA, Pickler TB, Gerenutti M, Grotto D. Shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes): absence of changes in maternal reproductive performance and embryofetal development in vivo. Int J Med Mushrooms. 2020;22(8):781-791. DOI: 10.1615/IntJMedMushrooms.2020035680

81. Laurino LF, Viroel FJM, Caetano E, Spim S, Pickler TB, Rosa-Castro RM, et al. Lentinus edodes exposure before and after fetus implantation: materno-fetal development in rats with gestational diabetes mellitus. Nutrients. 2019 Nov;11(11):2720. DOI: 10.3390/nu11112720

82. Maschio BH, Gentil BC, Caetano ELA, Rodrigues LS, Laurino LF, Spim SRV, et al. Characterization of the effects of the shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes), on severe gestational diabetes mellitus in rats. Int J Med Mushrooms. 2017;19(11):991-1000. DOI: 10.1615/IntJMedMushrooms.2017024498

83. Wu JY, Siu KC, Geng P. Bioactive ingredients and medicinal values of Grifola frondosa (maitake). Foods. 2021 Jan;10(1):95. DOI: 10.3390/foods10010095

84. Hu Q, Xie B. Effect of Maitake D-fraction in advanced laryngeal and pharyngeal cancers during concurrent chemoradiotherapy: a randomized clinical trial. Acta Biochim Pol. 2022 Sep;69(3):625-632. DOI: 10.18388/abp.2020_5996

85. Zhao F, Guo Z, Ma ZR, Ma LL, Zhao J. Antitumor activities of Grifola frondosa (maitake) polysaccharide: a meta-analysis based on preclinical evidence and quality assessment. J Ethnopharmacol. 2021 Nov;280:114395. DOI: 10.1016/j.jep.2021.114395

86. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev. 2002 Jun;7(3):236-239.

87. Nanba H, Kodama N, Schar D, Turner D. Effects of maitake (Grifola frondosa) glucan in HIV-infected patients. Mycoscience. 2000 Aug;41(4):293-295. DOI: 10.1007/BF02463941

88. Nishihira J, Sato M, Tanaka A, Okamatsu M, Azuma T, Tsutsumi N, et al. Maitake mushrooms (Grifola frondosa) enhances antibody production in response to influenza vaccination in healthy adult volunteers concurrent with alleviation of common cold symptoms. Funct Food Health Dis. 2017;7(7):462-482.

89. Serrano L, López AC, González SP, Palacios S, Dexeus D, Centeno-Mediavilla C, et al. Efficacy of a Coriolus versicolor-based vaginal gel in women with human papillomavirus-dependent cervical lesions: the PALOMA study. J Low Genit Tract Dis. 2021 Apr;25(2):130-136. DOI: 10.1097/LGT.0000000000000596

90. Choi EJ, Choi JK. Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis. Nutr Res Pract. 2023 Dec;17(6):1056-1069. DOI: 10.4162/nrp.2023.17.6.1056

91. Deng G, Lin H, Seidman A, Fornier M, D'Andrea G, Wesa K, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. 2009 Sep;135(9):1215-1221. DOI: 10.1007/s00432-009-0562-z

92. Mizuno T, Zhuang C. Maitake, Grifola frondosa: pharmacological effects. Food Rev Int. 1995;11(1):135-149. DOI: 10.1080/87559129509541024

93. Mallard B, Leach DN, Wohlmuth H, Tiralongo J. Synergistic immuno-modulatory activity in human macrophages of a medicinal mushroom formulation consisting of reishi, shiitake and maitake. PLoS One. 2019;14(11):e0224740. DOI: 10.1371/journal.pone.0224740

94. Vetvicka V, Vetvickova J. Immune-enhancing effects of maitake (Grifola frondosa) and shiitake (Lentinula edodes) extracts. Ann Transl Med. 2014 Feb;2(2):14. DOI: 10.3978/j.issn.2305-5839.2014.01.05

95. ScienceDirect [Internet]. Grifola frondosa [2023; cited 2023 Feb 23]. Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/grifola-frondosa

96. Camilleri E, Blundell R, Baral B, Karpiński TM, Aruci E, Atrooz OM. Unveiling the full spectrum of maitake mushrooms: a comprehensive review of their medicinal, therapeutic, nutraceutical, and cosmetic potential. Heliyon. 2024 Apr;10(9):e30254. DOI: 10.1016/j.heliyon.2024.e30254

97. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015.

98. Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, et al. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Exp Ther Med. 2012 Jun;3(6):925-930. DOI: 10.3892/etm.2012.537

99. Luk SU, Lee TKW, Liu J, Lee DTW, Chiu YT, Ma S, et al. Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One. 2011;6(5):e19804. DOI: 10.1371/journal.pone.0019804

100. Akagi J, Baba H. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients. Int J Clin Oncol. 2010 Apr;15(2):145-152. DOI: 10.1007/s10147-010-0033-1

101. Tsang KW, Lam CL, Yan C, Mak JC, Ooi GC, Ho JC, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med. 2003 Jun;97(6):618-624. DOI: 10.1053/rmed.2003.1490

102. Wang Y, Li H, Li Y, Zhao Y, Xiong F, Liu Y, et al. Coriolus versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation. Phytother Res. 2019 Oct;33(10):2737-2748. DOI: 10.1002/ptr.6448

103. Ajibola OO, Nolasco-Hipolito C, Carvajal-Zarrabal O, Salleh SF, Adeyinka GC, Adefegha SA, et al. Turkey tail mushroom (Trametes versicolor): an edible macrofungi with immense medicinal properties. Curr Opin Food Sci. 2024;58:101191. DOI: 10.1016/j.cofs.2024.101191

104. Dou H, Chang Y, Zhang L. Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Prog Mol Biol Transl Sci. 2019;163:361-381. DOI: 10.1016/bs.pmbts.2019.03.001

105. Chang Y, Zhang M, Jiang Y, Liu Y, Luo H, Hao C, et al. Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Discov Med. 2017 Apr;23(127):207-219.

106. Eliza WL, Fai CK, Chung LP. Efficacy of yun zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Pat Inflamm Allergy Drug Discov. 2012 Jan;6(1):78-87. DOI: 10.2174/187221312798889310

107. Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother. 2007 Jun;56(6):905-911. DOI: 10.1007/s00262-006-0248-1

108. Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother. 2006 Apr;55(4):404-411. DOI: 10.1007/s00262-005-0054-1

109. Thongbai B, Rapior S, Hyde KD, Wittstein K, Stadler M. Hericium erinaceus, an amazing medicinal mushroom. Mycol Progress. 2015 Oct;14:1-23. DOI: 10.1007/s11557-015-1105-4

110. Pegler DN. Useful fungi of the world: the monkey head fungus. Mycologist. 2003 Aug;17(3):120-121. DOI: https://doi. org/10.1017/S0269915X03003069

111. Wong KH, Naidu M, David RP, Bakar R, Sabaratnam V. Neuroregenerative potential of lion’s mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (higher Basidiomycetes), in the treatment of peripheral nerve injury (review). Int J Med Mushrooms. 2012;14(5):427-446. DOI: 10.1615/intjmedmushr.v14.i5.10

112. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2024. Lion’s mane; 2024 [cited 2024 Mar 2]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK599740/

113. Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125-131. DOI: 10.2220/biomedres.40.125

114. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009 Mar;23(3):367-372. DOI: 10.1002/ptr.2634

115. Cornford N, Charnley M. Hericium erinaceus: a possible future therapeutic treatment for the prevention and delayed progression of Alzheimer’s disease? – A narrative review. Nutr Res Rev. 2025 Feb;1-15. DOI: 10.1017/S0954422425000058

116. Kasahara K, Kaneko N, Shimizu K. Effects of Hericium erinaceum on aged patients with impairment. Gunma Med Suppl. 2001;76:77-78. In: Kawagishi H, Zhuang C, Yunoki R. Compounds for dementia from Hericium erinaceum. Drugs Future. 2008 Feb;33(2):149. DOI: 10.1358/dof.2008.033.02.1173290

117. La Monica MB, Raub B, Ziegenfuss EJ, Hartshorn S, Grdic J, Gustat A, et al. Acute Effects of naturally occurring guayusa tea and Nordic lion's mane extracts on cognitive performance. Nutrients. 2023 Dec;15(24):5018. DOI: 10.3390/nu15245018

118. Docherty S, Doughty FL, Smith EF. The acute and chronic effects of lion's mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients. 2023 Nov;15(22):4842. DOI: 10.3390/nu15224842

119. Chong PS, Fung ML, Wong KH, Lim LW. Therapeutic potential of Hericium erinaceus for depressive disorder. Int J Mol Sci. 2019 Dec;21(1):163. DOI: 10.3390/ijms21010163

120. Inanaga, K. Marked improvement of neurocognitive impairement after treatment with compounds from Hericium erinaceum: a case study of recurrent depressive disorder. Pers Med Univ. 2014;3:46-48. DOI: 10.1016/j.pmu.2014.02.004

121. Wang G, Zhang X, Maier SE, Zhang L, Maier RJ. In vitro and in vivo inhibition of Helicobacter pylori by ethanolic extracts of lion's mane medicinal mushroom, Hericium erinaceus (Agaricomycetes). Int J Med Mushrooms. 2019;21(1):1-11. DOI: 10.1615/IntJMedMushrooms.2018029487

122. Shang X, Tan Q, Liu R, Yu K, Li P, Zhao GP. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the lion's mane mushroom, Hericium erinaceus (higher Basidiomycetes). Int J Med Mushrooms. 2013;15(2):165-174. DOI: 10.1615/intjmedmushr.v15.i2.50

123. Wong JY, Abdulla MA, Raman J, Phan CW, Kuppusamy UR, Golbabapour S, et al. Gastroprotective effects of lion’s mane mushroom Hericium erinaceus (Bull.:Fr.) Pers. (Aphyllophoromycetideae) extract against ethanol-induced ulcer in rats. Evid Based Complement Alternat Med. 2013;2013:492976. DOI: 10.1155/2013/492976

124. Xu CP, Liu WW, Liu FX, Chen SS, Liao FQ, Xu Z, et al. A double-blind study of effectiveness of Hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report. Chin Med J (Engl). 1985 Jun;98(6):455-456.

125. Tiralongo J, Mallard B. Exploring the immunomodulatory effect of new mushroom formulations. 2021. Integria Healthcare, Griffith University. Unpublished data.

126. Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009 Jun;2:25. DOI: 10.1186/1756-8722-2-25

127. Li G, Yu K, Li F, Xu K, Li J, He S, et al. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers. J Ethnopharmacol. 2014 Apr;153(2):521-530. DOI: 10.1016/j.jep.2014.03.003

128. Thongbai B, Rapior S, Hyde KD, Wittstein K, Stadler M. Hericium erinaceus, an amazing medicinal mushroom. Mycol Progress. 2015 Oct;14:1-23. DOI: 10.1007/s11557-015-1105-4